212 related articles for article (PubMed ID: 18974182)
1. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity.
Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z
Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182
[TBL] [Abstract][Full Text] [Related]
2. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
3. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
Stupfler B; Birck C; Séraphin B; Mauxion F
Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148
[TBL] [Abstract][Full Text] [Related]
4. The BTG2 protein is a general activator of mRNA deadenylation.
Mauxion F; Faux C; Séraphin B
EMBO J; 2008 Apr; 27(7):1039-48. PubMed ID: 18337750
[TBL] [Abstract][Full Text] [Related]
5. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
Maryati M; Airhihen B; Winkler GS
Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
[TBL] [Abstract][Full Text] [Related]
6. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.
Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L
J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725
[TBL] [Abstract][Full Text] [Related]
7. Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking.
Ameerul A; Almasmoum H; Pavanello L; Dominguez C; Winkler GS
J Mol Biol; 2022 Jul; 434(14):167662. PubMed ID: 35640718
[TBL] [Abstract][Full Text] [Related]
8. The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4-NOT deadenylase complex.
Petit AP; Wohlbold L; Bawankar P; Huntzinger E; Schmidt S; Izaurralde E; Weichenrieder O
Nucleic Acids Res; 2012 Nov; 40(21):11058-72. PubMed ID: 22977175
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.
Horiuchi M; Takeuchi K; Noda N; Muroya N; Suzuki T; Nakamura T; Kawamura-Tsuzuku J; Takahasi K; Yamamoto T; Inagaki F
J Biol Chem; 2009 May; 284(19):13244-55. PubMed ID: 19276069
[TBL] [Abstract][Full Text] [Related]
10. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
11. Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex.
Yoshida Y; Hosoda E; Nakamura T; Yamamoto T
Jpn J Cancer Res; 2001 Jun; 92(6):592-6. PubMed ID: 11429045
[TBL] [Abstract][Full Text] [Related]
12. The mammalian anti-proliferative BTG/Tob protein family.
Winkler GS
J Cell Physiol; 2010 Jan; 222(1):66-72. PubMed ID: 19746446
[TBL] [Abstract][Full Text] [Related]
13. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
14. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
16. CAF1 plays an important role in mRNA deadenylation separate from its contact to CCR4.
Ohn T; Chiang YC; Lee DJ; Yao G; Zhang C; Denis CL
Nucleic Acids Res; 2007; 35(9):3002-15. PubMed ID: 17439972
[TBL] [Abstract][Full Text] [Related]
17. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
18. Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation.
Ruan L; Osawa M; Hosoda N; Imai S; Machiyama A; Katada T; Hoshino S; Shimada I
J Biol Chem; 2010 Sep; 285(36):27624-31. PubMed ID: 20595394
[TBL] [Abstract][Full Text] [Related]
19. Systematic mutagenesis of the leucine-rich repeat (LRR) domain of CCR4 reveals specific sites for binding to CAF1 and a separate critical role for the LRR in CCR4 deadenylase activity.
Clark LB; Viswanathan P; Quigley G; Chiang YC; McMahon JS; Yao G; Chen J; Nelsbach A; Denis CL
J Biol Chem; 2004 Apr; 279(14):13616-23. PubMed ID: 14734555
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure and functional properties of the human CCR4-CAF1 deadenylase complex.
Chen Y; Khazina E; Izaurralde E; Weichenrieder O
Nucleic Acids Res; 2021 Jun; 49(11):6489-6510. PubMed ID: 34038562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
